We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONCY
2001
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$3K ﹤0.01%
2,000
– –
RCPT
2002
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$3K ﹤0.01%
+74
New +$3.18K
BTUI
2003
DELISTED
BTU INTERNATIONAL INC
BTUI
$3K ﹤0.01%
1,000
– –
DLX icon
2004
Deluxe
DLX
$1.19B
$2K ﹤0.01%
+50
New +$2.51K
NWS icon
2005
News Corp Class B
NWS
$16.4B
$2K ﹤0.01%
125
– –
OXSQ icon
2006
Oxford Square Capital
OXSQ
$151M
$2K ﹤0.01%
320
– –
SGU icon
2007
Star Group
SGU
$428M
$2K ﹤0.01%
500
– –
TCRT icon
2008
Alaunos Therapeutics
TCRT
$4.74M
$2K ﹤0.01%
4
– –
TTPH
2009
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2K ﹤0.01%
+10
New +$2.79K
MSBF
2010
DELISTED
MSB Financial Corp.
MSBF
$2K ﹤0.01%
+342
New +$2.45K
TECD
2011
DELISTED
Tech Data Corp
TECD
$2K ﹤0.01%
47
– –
CPN
2012
DELISTED
Calpine Corporation
CPN
$2K ﹤0.01%
129
– –
FCVA
2013
DELISTED
FIRST CAPITAL BANCORP (VA)
FCVA
$2K ﹤0.01%
500
– –
GTI
2014
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$2K ﹤0.01%
200
-1,850
-90% -$19.6K
VTSS
2015
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$2K ﹤0.01%
538
-18,059
-97% -$67K
SCMR
2016
DELISTED
SYCAMORE NETWORKS INC NEW
SCMR
$2K ﹤0.01%
4,026
– –
ASCMA
2017
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$2K ﹤0.01%
36
– –
COSN
2018
DELISTED
COSINE COMMUNICATIONS INC COM NEW
COSN
$2K ﹤0.01%
1,000
– –
OREX
2019
DELISTED
Orexigen Therapeutics, Inc.
OREX
$2K ﹤0.01%
+44
New +$2.98K
EE
2020
DELISTED
El Paso Electric Company
EE
$2K ﹤0.01%
74
– –
DOC
2021
DELISTED
PHYSICIANS REALTY TRUST
DOC
$2K ﹤0.01%
202
-19
-9% -$247
PKO
2022
DELISTED
Pimco Income Opportunity Fund
PKO
$2K ﹤0.01%
+100
New +$2.87K
AES icon
2023
AES
AES
$10.6B
$1K ﹤0.01%
83
– –
AGNC icon
2024
AGNC Investment
AGNC
$12.3B
$1K ﹤0.01%
106
– –
ANSS
2025
DELISTED
Ansys
ANSS
$1K ﹤0.01%
19
– –
79 80
81
82 83

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.